Cardiovascular Strategic Roundup | July 23–August 26, 2026
Cardiovascular Strategic Roundup exploring Developments and Competitive Shifts…
Lundbeck Expands EVERSANA AI Commercialization | Lucid Diligence Brief
Lundbeck Expands EVERSANA AI Across Its U.S. Commercial Organization…
Endocrinology Strategic Roundup | July 21–August 24, 2026
Endocrinology Strategic Roundup exploring Key Strategic Developments and…
Conavi Medical Raises C$10 Million in Public Offering | Lucid Diligence Brief
Conavi Medical’s C$10M Financing Puts Novasight U.S. Adoption and Funding…
Insulinova Partners with Ospedale San Raffaele | Lucid Diligence Brief
Avaí Bio and Insulinova Test Encapsulated Beta Cells With San Raffaele as…
Curium Lantheus Merger | Lucid Diligence Brief
Curium’s proposed acquisition of Lantheus reshapes the radiopharmaceutical…
Genprex Roche Diagnostics TROP2 Collaboration | Lucid Diligence Brief
Genprex and Roche Diagnostics begin TROP2 assay validation to support…
Roche Ivy Tech Laboratory Workforce Partnership | Lucid Diligence Brief
Roche Diagnostics and Ivy Tech launch an Indiana laboratory workforce…
Massive Bio and GELL Partnership | Lucid Diligence Brief
Massive Bio and GELL have launched a strategic partnership to expand AI-enabled…
Harbour BioMed and Sinopharm Innovation Consortium Expands Biologics Strategy | Lucid Diligence Brief
Harbour BioMed partners with Sinopharm to establish an innovation consortium…
Cardiovascular Strategic Roundup | June 25–July 21, 2026
Cardiovascular Strategic Roundup exploring Developments and Competitive Shifts…
Evogene and ELEO Oral PCSK9 Collaboration | Lucid Diligence Brief
Evogene and ELEO Oral PCSK9 discovery collaboration launches as Merck’s…